Cyclazodone
![]() | |
Systematic (IUPAC) name | |
---|---|
(RS)-2-(cyclopropylamino)-5-phenyl-1,3-oxazol-4-one | |
Clinical data | |
Routes of administration | Oral |
Legal status |
|
Identifiers | |
CAS Number |
14461-91-7 ![]() |
ATC code | none |
PubChem | CID 26701 |
ChemSpider |
24875 ![]() |
UNII |
O8U55ZRL9K ![]() |
ChEMBL |
CHEMBL2106536 ![]() |
Chemical data | |
Formula | C12H12N2O2 |
Molar mass | 216.090 g/mol |
Chirality | Racemic mixture |
| |
| |
![]() ![]() |
Cyclazodone is a centrally acting stimulant drug developed by American Cyanamid Company in the 1960s.[1] The drug is related to other drugs such as pemoline and 4-methylaminorex. It is a banned stimulant under the World Anti-Doping Agency prohibited list.[2]
See also
References
- ↑ US Patent 3,321,470 - 5-Arylidene-2Amino-2-Oxazolin-4-Ones
- ↑ World Anti-Doping Agency 2008 Prohibited List
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.